异甘草酸镁减轻甲氨蝶呤肝肠毒性的机制研究
本研究在大鼠模型中探讨异甘草酸镁(MgIG)对甲氨蝶呤(MTX)所致肝毒性和肠道毒性的保护作用及机制。预防性给予MgIG(9、18 mg/kg/天)可显著降低MTX(20 mg/kg)静脉注射后血清AST、ALT水平,减轻肝纤维化与肝细胞凋亡,并降低肠道COX-2表达、肠通透性和炎症。结论提示MgIG可能通过降低COX-2等途径减轻MTX化疗的肝肠副作用。
要点
- MgIG预防性给药可降低MTX所致大鼠血清AST、ALT升高。
- MgIG减轻MTX诱导的肝纤维化与肝细胞凋亡,效果优于还原型谷胱甘肽。
- MgIG可降低MTX诱导的肠道COX-2表达、肠通透性及炎症。
核心结论
- MgIG对MTX诱导的肝毒性和肠道损伤具有保护作用,可能成为减轻MTX化疗肝肠副作用的候选药物。
研究设计与样本
- 研究在大鼠模型中预防性给予MgIG(9和18 mg/kg/天),并以还原型谷胱甘肽(80 mg/kg/天)作对照,观察MTX(20 mg/kg体重)静脉注射后的肝肠毒性指标。
主要发现
- MgIG(9和18 mg/kg/天)显著降低接受MTX(20 mg/kg)静脉注射大鼠血清AST和ALT水平。
- MgIG减轻MTX诱导的肝纤维化,并比还原型谷胱甘肽(80 mg/kg/天)更好地保护肝细胞凋亡和降低血清丙二醛水平。
- MgIG给药后,MTX诱导的COX-2表达、肠道通透性和炎症均减轻。
- MgIG(9和18 mg/kg)减少MTX诱导的肠绒毛中ZO-1与Cx43共定位。
临床怎么用
- 对于接受MTX化疗且出现肝肠毒性风险的患者,MgIG或可作为潜在辅助用药,但需临床研究验证。
局限性
- 本研究为大鼠实验,结果不能直接外推至临床人群,需进一步临床试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Magnesium isoglycyrrhizinate (MgIG), which has been widely employed to treat chronic hepatitis, is synthesized from 18-β glycyrrhizic acid, a main component of traditional Chinese medicine Glycyrrhiza uralensis Fisch. Although the protective effects of MgIG on methotrexate (MTX)-induced liver toxicity have been well-documented, the underlying mechanism remains elusive. MTX was initially used to treat pediatric acute leukemia, and has been widely applied to psoriasis therapy. However, its clinical applications are limited due to hepatotoxicity and intestinal toxicity. Herein, prophylactic administration of MgIG (9 and 18 mg/kg/day) significantly reduced the levels of aspartate aminotransferase and alanine aminotransferase in the serum of rats receiving intravenous injection of MTX (20 mg/kg body weight). MgIG also attenuated MTX-induced hepatic fibrosis. Moreover, it better protected against MTX-induced hepatocyte apoptosis and decreased the serum level of malondialdehyde than reduced glutathione (80 mg/kg/day) did. Interestingly, MTX-induced cyclooxygenase-2 (COX-2) expression, intestinal permeability and inflammation were attenuated after MgIG administration. In addition, MgIG (9 and 18 mg/kg) reduced MTX-induced colocalization of zonula occludens-1 (ZO-1) and connexin 43 (Cx43) in intestinal villi. In conclusion, MgIG exerted beneficial effects on MTX-induced hepatotoxicity and intestinal damage, as a potentially eligible drug for alleviating the hepatic and intestinal side effects of MTX during chemotherapy.
引用
- Cao Y, Shi H, Sun Z, et al. Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2. Front Pharmacol. 2019. PMID: 30971913. doi:10.3389/fphar.2019.00119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。